Cite

HARVARD Citation

    Ono, N. et al. (n.d.). Enhanced antitumor activity of erlotinib in combination with the Hsp90 inhibitor CH5164840 against non‐small‐cell lung cancer. Cancer science. 104 (10), pp. 1346-1352. [Online]. 
  
Back to record